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1. Introduction 
1.1 Middle and long latency auditory evoked potentials and their usage in 
fibromyalgia 
FM is a chronic syndrome that occurs predominantly in women and is marked by 
generalized pain, multiple defined tender points, fatigue, disturbed sleep, cognitive 
difficulty, and numerous other somatic complaints. The etiology and pathophysiology of 
FM remain unclear. Despite extensive research, no structural pathology has been identified 
in muscles or other tissues. The general and widespread nature of pain in FM strongly 
suggests the involvement of central mechanisms (Williams et al., 2006). Although 
psychological factors associated with chronic distress appear to be important for the 
development of FM in many patients, abundant evidence now indicates that pain in FM 
reflects abnormal pain processing in the central nervous system (ie. central sensitivity) 
(Herrero JF et al., 2000, Staud R. et al, 2001). Recent research suggested that FM patients 
might have deficiencies in central inhibitory mechanisms, such as diffuse noxious inhibitory 
control or the endogenous pain inhibitory system. Nevertheless, little is yet known about the 
brain mechanisms involved in the processing of nonpainful somatosensory information in 
FM (Monyoto P et al., 2006, Julien N. Et al., 2005). 
Central mechanisms related to pathophysiology and hypervigilance have long been 
discussed for fibromyalgia. Nevertheless, research into this issue has been inconclusive so 
far. Our aim to design this study (Turker et al., 2008) was to determine whether central 
mechanisms played an important role in fibromyalgia via examining brain activity elicited 
by auditory evoked potentials in patients with FM and to assess relationship with clinical 
variables. 
Middle latency evoked potentials (Middle Latency Auditory Evoked Potentials) are 
composed of several components that can be recorded from 10 to 50 msec after stimulus 
onset. The most stable components are Na and Pa, with latencies between 16-30 msec and 
30-45 msec, respectively. Most of the MLAEP complex is thought to originate near the 
auditory cortex, although No, Po and Na may be generated by subcortical structures. 
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1.2 Patients and methods  
33 female patients with a diagnosis of FM and 37 healthy women participated in the study. 
All patients met the American College of Rheumatology (ACR) criteria for FM (Wolfe et al., 
1990).  
Eighteen tender points accepted by the ACR for FM were evaluated. Each tender point was 
rated from 0 point (no pain) to 3 points (most severe pain). The sum of the 18 tender points 
was calculated as the total myalgic score (TMS). Other symptoms of FM were evaluated by 
using the Fibromyalgia Impact Questionaire (FIQ) and Health Assesment Questionary 
(HAQ) (Küçükdeveci et al.,2004,Bennett et al.,2005). The HAQ functional disability index 
was used to assess functional status. The instrument asks 24 questions regarding 8 activities 
of daily living areas. 
The FIQ is a 20-item, self report instrument that measures multiple symptoms, functioning, 
and overall well-being. The first 10 items comprise a physical functioning scale; each item is 
rated on a 3-point Likert-type scale. On items 11 and 12, subjects indicate the days that they 
feel well or miss work because of fibromyalgia symptoms. Items 14 through 20 rate the 
difficulty in performing their job responsibilities, pain, fatigue, morning tiredness, stiffness, 
anxiety, and depression on a 10-cm visual analog scales (VAS). All subscores with the 
exception of the two work-related scores and physical function score were summed to yield 
the total score of fibromyalgia impact, which ranges from 0 (no impact) to 70 (maximum 
impact). Global disease severity was assessed with visual analogue scale (VAS) (0=very 
good, 10=very poor). The Hamilton Rating Scale for Depression and Hamilton Rating Scale 
for Anxiety were used to evaluate the affective condition of patients with FM (Hamilton et 
al., 1967). 
Patients were excluded if they had evidende of traumatic injury, inflammatory rheumatic 
disease, a history of seizure, head trauma, or cerebrovascular disease; a lifetime history of 
pyschosis, or dementia; alcohol or substance dependence; if they received psychiatric 
treatment in the last 3 weeks or if there was a history of auditory impairment.  
1.3 Evoked potentials recording procedure 
All recordings of MLAEPs were performed at Dantec Keypoint. Electrode montage was 
adjusted as active electrode placed on ipsilateral mastoid and reference and ground 
electrodes at Cz and Fz, respectively. Silver surface electrodes were used for reference and 
ground electrodes. A scalp needle electrode was used as active electrode. Alternating clicks 
of 100 μsec duration were used and polarity was adjusted as vertex. The frequency of 
stimulation was 10/sec and the filtering was chosen as 10 Hz–200 Hz. Analysis time (sweep 
length) and sensitivity were 100msec and 0,2 µv/d, respectively. The intensity of the stimuli 
was chosen according to the auditory threshold. The ipsilateral ear was stimulated with an 
intensity of stimulus such as hearing threshold plus 60 DB, while the contralateral ear was 
masked with white noise. Averaging of 1000 signals was performed twice and overlapped 
for each ear. No, Po, Na, Pa, Nb, and Pb were sampled and latencies and amplitudes of each 
potential were determined and compared with age and gender matched controls. MLAEPs 
recordings were performed bilateraly i.e. 30 recordings were performed for patients and 30 
recordings were performed for controls making a total of 60 recordings. No artifact rejection 
was employed. As hearing impairment can alter the MLAEPs, prior to beginning testing, the 
external ear canal was checked with an otoscope to assure that the canal was not blocked by 
cerumen. Patients with hearing problems assessed by otologic tests were excluded. MLAEPs 
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are known to be affected by medications, however all patients were under treatment and 
there was no other way to investigate them. 
Recordings of MLAEPs and LLAEPs (Long latency auditory evoked potentials) were 
performed for both patients and controls, using an active electrode placed on ipsilateral 
mastoid and reference and ground electrodes at Cz and Fz, respectively. Binaural 
stimulation was performed for LLAEPs. No, Po, Na, Pa, Nb, and Pb were sampled for 
MLAEPs. N1, P1, N2 and P2 were sampled for LLAEPs. Latencies and amplitudes of each 
potential were compared with those of controls and correlation between clinical and 
electrophysiological parameters were investigated statistically. Our study was approved by 
the local committee of ethics. 
1.4 Statistical methods 
Statistical evaluation of data was performed via using descriptive statistical methods such as 
mean and standard deviations while student T test was used for quantitative data showing 
normal statistical distribution. Pearson and Spearman’s correlation analysis methods were 
used to investigate the correlation between latencies of MLAEP and clinical parameters. The 
results were evaluated at a confidency interval of 95% and a statistical significancy of p< 
0.05. Comparisons between groups were made using the chi-square test for categorical 
variables. No statistically significant differences were recognized in the comparison of 
demographical data (age, disease duration, education, occupation, education level and 
marital status) between the groups. Clinical measures of patients are shown in table 1. 
 
Clincal parameter Mean SD 
HAQ (0-3) 0,87 0,48 
Number of tender points(11-18) 14,90 4,14 
Total myalgia score 35,09 13,22 
Anxiety score 23,06 9,75 
Depression score 19,15 8,94 
Global disease severity(0-10) 6,72 1,89 
 Mean SD 
FIQ Total (0-70) 51,57  15,08 
Physical function score  (0 – 30) 11,63  5,49 
HAQ: Health Assesment Questionary FIQ: Fibromyalgia Impact Questionaire 
Table 1. Clinical measures of patients. 
1.5 Results 
The latencies of Na, Nb and Pb of MLAEPs in the patient group were statistically longer 
when compared with those of the healthy controls (p<0.05, p<0.01 and  p<0.01 respectively). 
However No, Po and Pa did not show any statistical significant difference between the 
groups (Student t test). Latency of Na had statistically significant positive correlations with 
disease duration, FIQ total score, physical score and number of tender points (p<0.05). 
Latency of Pa had statistically significant positive correlations with age, disease duration, 
FIQ total score, physical score and FIQ 2, FIQ 3, FIQ 4 and FIQ 6 (p<0.05, p<0.01, p<0.05, 
p<0.05, p<0.01, and p<0.05 for the rest respectively) (Figure 1). Latency of Nb had 
www.intechopen.com
 
EMG Methods for Evaluating Muscle and Nerve Function 
 
212 
statistically significant positive correlations with disease duration (p<0.05) (Figure 2), FIQ 
total score (p<0.05), FIQ 2 (p<0.01), FIQ 6 (p<0.05), global disease severity (p<0.05). Latency 
of Pb had statistically significant positive correlations with FIQ total score (p<0.05), FIQ 2 
(p<0.05) and global disease severity (p<0.05) (Pearson and Spearman’s correlation tests). 
Evaluation of groups regarding parameters of LLAEP showed that latencies of P1, N2 and 
P2 were statistically longer when compared with those of the healthy controls (p<0.05, 
p<0.01 and p<0.01 respectively) whereas N1 did not show any statistical significancy 
between the groups (Student t test). 
 
 
Fig. 1. Correlation analysis of Pa latency and disease duration. 
Correlation studies of latencies of LLAEPs with clinical parameters showed that FIQ total 
score had a positive and statistically significant correlation with latency of N2 (p<0.05), 
while the same was valid for physical score and FIQ2 with latency of N1 (p<0.05). FIQ 5, 7 
and 8 were positively correlated with latency of N2 (p<0.05, p<0.01 and p<0.01 respectively), 
while FIQ 9 and 10 were positively correlated with latency of N1 (p<0.01,  
p<0.05 respectively). HAQ and anxiety score had positive correlations with latency of N2 
(p<0.05). 
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The amplitudes of Po, Pa and Nb of MLAEPs and P1, N1, P2 and N2 of LLAEPs in the 
patient group were statistically significantly very low when compared with those of the 
healthy controls (p<0.01) (Student t test). However, there were not any statistical significant 
differences of amplitudes of MLAEPs and LLAEPs between patients having different 
disease durations. Patients suffering from fibromyalgia for five or more than five years did 
not show statistically higher or lower amplitudes when compared with patients having the 
disease for less than five years. Patients having myalgia scores equal or more than 40 also 
did not show any statistical differences of amplitudes of MLAEPs and LLAEPs when 
compared with patients having myalgia scores less than 40. Patients having anxiety scores 
equal or more than 25 were also compared with the ones having scores less than 25 and no 
statistically significant differences of amplitudes were found. Same results were obtained 
when patients were compared regarding latencies of both MLAEPs and LLAEPs. 
 
 
Fig. 2. Correlation analysis of Nb latency and disease duration. 
A LLAEP trace of one of the patients with long latencies is shown in Fig. 3. 
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Fig. 3. A LLAEP trace of one of the patients with long latencies. 
Correlation studies of amplitudes of LLAEPs with clinical parameters did not point out to 
any results of statistical significancy, whereas only one electrophysiological parameter in 
MLAEP amplitudes did. Amplitude of No showed a negative correlation with number of 
tender points (p<0.05) (Figure 4). 
 
 
Fig. 4. Correlation analysis of number of tender points and amplitude of No. 
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Latencies of Na, Nb and Pb were statistically significantly longer in the patient group when 
compared with controls (p<0.05 and p<0.01 respectively).  
The most important results for our study pointed out that Na, Pa and Nb latencies had 
positive correlations with disease duration which were statistically significant (p<0.05, 
p<0.01 and p<0.05 respectively) while the correlations between Na and HAQ and myalgia 
scores were positive although statistically insignificant (p>0.05). On the other hand, the 
number of tender points had a statistically significant positive correlation with Na (p<0.05). 
FIQ2 scores had negative and statistically very significant correlations with Pa and Nb 
(p<0.01 for both) while FIQ3 and FIQ scores had statistically positive correlations with Pa 
(p<0.05).  
1.6 Discussion 
Since 1990s, some possible explanations for the involvement of central pathways in 
fibromyalgia are discussed in various papers, though their number is still limited. To our 
knowledge, correlation of clinical parameters of fibromyalgia with MLAEPs has not been 
studied before.  
In 1995, Johansson et al., reported significant focal flow decreases in dorsolateral frontal 
cortical areas of both hemispheres of fibromyalgic patients (Johansson et al., 1995). The 
AEPs also showed signs of dysfunction at least at the brainstem level. A large group of 
fibromyalgia patients were studied electrophysiologically by Rosenhall et al. in 1996 and 
significant differences were found in the study group regarding absolute and interpeak 
latencies in short latency AEPs, when compared with normals (Rosenhall et al, 1996). 
However sensorineural hearing loss was reported in 15% of patients. Bayazit et al., also 
studied short latency AEPs in fibromyalgia patients with and without cochleovestibular 
symptoms and reported no statistical difference of AEP abnormalities in these subgroups 
indicating that FM patients might complain of otologic symptoms without having a 
detectable ear disease and that a neural disintegration or some other events related to neural 
mediators might be the mechanism involved (Bayazit et al.,2002). Our group of patients did 
not have otological symptoms, however their MLAEPs showed statistically significant 
differences when compared with normal controls. This result of our study may be 
considered as being in agreement with the above study. Fann et al. studied MLAEPs in a 
similar patient group (chronic low back pain) and found a trend of increased latencies and 
lower amplitudes of P50 potential in the study group reporting also a decreased habituation 
of this very potential (Fann et al.,2005). Our study also indicated that Na, Nb and Pb 
(namely N16, N40 and P50 potentials) had longer latencies in the patient group when 
compared with normals. The origins of MLAEPs are still controversial. Most authors share 
the opinion that Pa potential (P30) is generated in the supratemporal auditory center of each 
hemisphere, but it is not clear that Pa represents the earliest cortical auditory response. Na 
and Pa are believed to be related with the activation of of the primary auditory cortex. Some 
authors imply that Pa is generated in the auditory cortex while Na is originated 
subcortically. No, Po and Na have origins of subcortical structures while most other MLAEP 
potentials have origins generated from sites near the auditory cortex. In 1991 Erwin RJ et al. 
reported that P50 (Pb) was generated in thalamus (Erwin RJ et al., 1991). In a review of 
functional MRI (Magnetic resonance imaging) findings in FM, decreased rCBF (regional 
cerebral blood flow) in the thalamus and in the caudate nucleus was reported as results of 
various studies, nevertheless indicating the fact that this finding was not unique to FM. 
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Latency, on the other hand, has been shown to reflect the efficiency and speed of 
information processing in cognitive function (Gracely et al., 2002). 
Thus results of our study may well be interpreted that FM patients show a slower speed of 
information processing in areas which are responsible for complex auditory perceptions 
related highly to cognitive functions. In 2006 Montaya et al. found significant amplitude 
reductions in FM patients for the auditory but not the somatosensory modality and 
suggested also that there was abnormal information processing in FM patients characterized 
by a lack of inhibitory control to repetitive nonpainful somatosensory information during 
stimulus coding and cognitive evaluation (Montoya et al., 2006). Roth et al. also stated that 
women with chronic pain were particularly vulnerable to cognitive dysfunction in a study 
designed as a cross-sectional survey (Roth et al., 2005). 
1.7 Conclusion 
Our results may be interpreted that central mechanisms may be important in the evolution 
of fibromyalgia. CNS dysfunction may be both an etiological factor in the fibromyalgia 
syndrome and a pathophysiological mechanism explaining the clinical symptoms and signs. 
2. The relationship between middle latency auditory evoked responses, and 
the neuropsychological profile in patients with schizophrenia  
2.1 Introduction 
Although variable time ranges are described for MLAEPs, recent reliable sources report that 
the middle latency auditory evoked responses (MLAEPs) are far-field potentials that appear 
between 10-50 ms following an auditory stimulus and are recorded on vertex. The upper 
range limit is also reported as 80-100 ms in some sources (Buchwald et al., 1989; Buchwald et 
al., 1991; Erwin et al., 1986; Erwin et al., 1987; Mauguire et al., 2007). Far field potentials are 
generated by movement of the charge, but the electrode sees the moving front of 
depolarization and repolarization rather than the direct charge flow between regions of 
depolarization and repolarization. Most evoked potentials are generated by charge 
movement in nerve tracts to and from the relay nuclei and are far-field potentials because of 
the depth of the neural generators. The near-synchronous volley of action potentials in the 
nerve tracts produces far-field potentials that are recorded at scalp electrodes (Mauguire et 
al., 2007). 
In literature, it has been assumed that MLAEPs are composed of six waves; No, Po, Na, Pa, 
Nb, Pb. No and Po are the the earliest responses. Pa and Pb (P1, P50) are defined as positive 
waves occurring in the 29 msec and 45 msec after a stimulus, while Na and Nb are negative 
deflections in the 25 msec and 50 msec, respectively. The neural sources of these waves are 
still controversial (Misulis et al., 2001, Cacace et al., 1990). Most of the MLAEP complex is 
thought to originate near the auditory cortex, although No, Po and Na may be generated by 
subcortical structures.  
Among components of MLAEPs, the most commonly studied wave is the Pb (synonyms: P1 
or P50). The P1 potential is blocked by the muscarinic anticholinergic drugs. It is present 
during waking and rapid eye movement sleep and does not exist during deep slow wave 
sleep. It has also been reported that the P1 component may be associated with cognitive 
processes, especially attention and state. Abnormalities of MLAEPs have been reported in 
some neurodegenerative and psychiatric diseases such as Alzheimer’s disease, Parkinson’s 
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disease, schizophrenia, Huntington disease and autism (Buchwald et al.,1989, Woods et al., 
1987, Green et al., 1995). 
It has been assumed that latency in evoked potential studies reflect the efficiency and speed 
of information processing. Thus, the prolonged latency may reflect that the information 
processing speed slowed. Amplitude abnormalites, on the other hand, refer to axonal loss in 
related areas and show the overall efficiency of neural structures mediating a response. 
Over thirty years, various MLAEP studies have been performed in patients with 
schizophrenia. In most of these studies, the sensory gating paradigm has been investigated 
and they demonstrated the P1 habituating phenomenon, recovery cycle abnormalities and 
P1 suppression deficiency (Aminoff et al., 1990; Buchwald et al., 1992; Dickerson et al., 1991). 
However the relationship between the P1 latencies, amplitudes and neurocognitive status 
stil remains unclear. In this study (Sahin et al, 2005; Turker et al., 2008) we investigated 
whether the MLAEPs correlated with the performances of neuropsychological tests in 
patients with schizophrenia and healthy controls.  
2.2 Methods 
2.2.1 Subjects 
We examined 15 patients (8 female and 7 male) with schizophrenia, who met diagnostic 
criteria of DSM-IV for schizophrenia and compared them with control subjects (9 females 
and 6 males). Patients and control subjects were matched for age, gender, education levels 
and handedness.  
Subjects who had other neurological or psychiatric disease, history of substance abuse and 
head trauma were not included in the study. All patients were psychiatrically stable (there 
were no psychotic symptoms and medication changes within at least two weeks prior to the 
assesment). Psychopathological symptoms severity in patiens was assessed by Positive and 
Negative Syndrome Scale (PANSS) (First, 1997). Informed consent was obtained from 
patients and control subjects before the study. 
2.2.2 Evoked potentials recording procedure 
All recordings of MLAEPs were performed at Dantec Keypoint. Electrode montage was 
adjusted as active electrode placed on ipsilateral mastoid and reference and ground 
electrodes at Cz and Fz, respectively. Silver surface electrodes were used for reference and 
ground electrode while a scalp needle electrode was used as active electrode. Alternating 
clicks of 100 μsec duration were used and polarity was adjusted as vertex. The frequency of 
stimulation was 10/sec and the filtering was chosen as 10 Hz-200 Hz. Analysis time (sweep 
length) and sensitivity were 100msec and 0,2 µv/d, respectively. The intensity of the stimuli 
was chosen according to the auditory threshold. The ipsilateral ear was stimulated with an 
intensity of stimulus such as hearing threshold plus 60 dB, while the contralateral ear was 
masked with white noise. Averaging of 1000 signals was performed twice and overlapped 
for each ear. No, Po, Na, Pa, Nb, and Pb were sampled and latencies and amplitudes of each 
potential were determined and compared with age and gender matched controls. MLAEPs 
recordings were performed bilateraly i.e. 30 recordings were performed for patients and 30 
recordings were performed for controls making a total of 60 recordings. No artifact rejection 
was employed. 
In MLAEP recording procedure, latency and amplitude measurements are usually done on 
the display, either manually or by an automatic peak detection algorithm that seeks the 
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maximum value between preset time values. The amplitude can be expressed as a peak to 
peak value between adjacent positive and negative components or the peak value can be 
measured against some baseline, usually taken just before the stimulus is presented. Latency 
for MLAEPs can be described as the time till the peak of the negative or the positive 
potential has evolved and this may be labelled on the display after the click (Erwin et al., 
1987) 
As hearing impairment can alter the MLAEPs, the external ear canal was checked with an 
otoscope to assure that the canal was not blocked by cerumen before the test. Patients with 
hearing problems assesed by otologic tests were excluded. MLAEPs are known to be 
affected by medications, however all patients were under treatment and there was no other 
way to investigate them. 
2.2.3 Neuropsychological evaluation 
An extensive neuropsychological test battery was used to assess the cognitive functions; 
attention, language, visuospatial functions, verbal and visual memory, executive functions 
(Table 3). 
2.2.4 Statistical methods 
The age, gender, handedness, education, the latencies and amplitudes of MLAEPs the 
neuropsychological test parameters of the patients and controls groups were compared with 
student-t test. The pearson correlation coefficient was used to determine the correlation 
between PANNS scores, the neuropsychological test parameters, and disease duration.  
2.3 Results 
The demographic features of patient and control groups are presented in Table 2. There 
were no statistically significant difference between age, gender, handedness, and education 
levels of patient and control groups.  
 
 Patients (n = 15)  Controls (n = 15) p 
Age  32.9 ± 10.6 29.8±2.3 NS  
Education 12.1 ±  3.7 12.6±2.6 NS  
MMSE 28.1 ± 2.7 29.6±0.8 S  
Gender  8M. 7F 9M. 6F  NS 
Duration of disease (month) 135.3± 112.1 (-)  (-) 
Table 2. Demographic Features. 
2.3.1 Neuropsychological tests 
Results are summarized in Table 4. Generally, in all the neuropsychological tests, 
performance of the patient group was poor when compared to control group. MMSE scores 
of the patient group were statistically significantly lower than those of the control groups.  
There were statistically significant differences regarding the attention and the language 
tests. The scores of the tests assessing visuospatial functions, except BLO, were significantly 
different between patient and control groups. Also, patients got statistically significant 
lower scores on memory tests, and executive functions when compared with controls. 
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Mini mental state examination (MMSE) 
Attention 
    WAIS-R Digit Span (DS) 
    Verbal Fluency (K-A-S Test) 
Language 
    Boston Naming Test (30-items) 
Visuo-spatial Functions 
    Benton’s Line Orientation Test (BLO) 
    Benton’s Facial Recognition Test (BFR) 
    WAIS-R BlocK Design (BD) 
    Hooper Visual Organization Test (HVOT) 
    Clock Drawing 
Verbal Memory 
    California Verbal Learning Test (CVLT) 
Visual Memory 
    WAIS-R subtest 
Executive Functions 
    Wisconsin Card Sorting Test (WCST) 
    Stroop Test 
    Trail Making Test A and B (TMT A-B) 
WAIS = Wechsler Adult Intelligence Scale. 
Table 3. Neuropsychological Test Battery. 
 
 Patients (n = 15) Controls (n = 15)  
 Mean SD Mean SD p 
MMSE 28.1 2.7 29.6 0.8 S 
Attention 
WAIS-R DS-fwd 6 1.06 7.2 1.01 S 
WAIS-R DS-bwd 3.6 1.29 5.2 1.08 S 
Verbal Fluency (K-A-S Test) 35.07 13.96 48.47 12.18 S 
       K-A-S perseveration 0.67 0.81 0.07 0.25 S 
Language  
Boston Naming Test (30-items) 27.60 2.79 29.27 1.28 S 
Visuo-spatial Functions 
BLO 23.43 7.94 26.40 2.99 NS 
BFR 18.07 3.38 21.93 2.63 S 
BD 21.14 11.43 30.20 9.59 S 
HVOT 17.79 4.04 21.00 1.89 S 
Clock Drawing 9.26 0.79 9.93 0.25 S 
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 Patients (n = 15) Controls (n = 15)  
 Mean SD Mean SD p 
Verbal Memory 
CVLT 
      Total of 5 trails 38.71 10.57 51.46 6.94 S 
      Long-delay free recall 7.92 2.97 12.53 2.06 S 
      Long-delay cued recall 8.21 2.96 13.20 1.65 S 
      Perseverations 5 4.11 3.40 3.08 NS 
      Free recall intrusions 2 2.21 1 1.81 NS 
      Cued recall intrusions 1.21 1.67 0.67 1.11 NS 
      Recognition 13.21 3.01 15.13 1.06 S 
      Discriminability (%) 88.09 9 96 3.5 S 
      False positive 1.5 1.6 0.46 1.06 S 
Visual Memory 
WAIS-R subtest 8 3.2 11.67 1.1 S 
Executive Functions 
WCST 
       Total number of responses 117.50 18.25 95.6 15.37 S 
       Total categories completed 3.57 2.10 5.93 0.25 S 
       Number of perseverative responses 43.36 36.23 12.67 4.25 S 
       Total number of errors 51.64 25.42 22.67 8.30 S 
       Total number of correct responses 65.86 14.72 72.93 8.40 NS 
Stroop 3 14.3 4 11.1 2.7 S 
Stroop 5 27.9 9.6 25.1 8.2 NS 
TMT A 69.72 25.7 35.35 13.18 S 
TMT B 146.44 91.55 75.56 25.13 S 
Table 4. Neuropsychological Test Results. 
2.3.2 Evoked potentials 
The results indicated that most of the MLAEPs data elicited from the patients showed 
statistically significant differences from controls. The pathological responses from both sides 
of the brains of patients did not differ significantly from each other as both right and left 
sides generated MLAEPs which were statistically significantly different from controls (Table 
5–6). Apart from NoR and PaL, all latencies of other parameters of MLAEPs were prolonged 
in the patient group (Table 5). Apart from PbR, amplitudes of parameters of MLAEPs were 
statistically significantly lower in the patient group when compared with the control group, 
(Table 6).  
We also found no correlations between PANSS scores, the scores of neuropsychological 
tests, the duration of disease, and the latencies and amplitudes of MLAEPs. 
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 Patients  (n=15) Control (n=15)  
 Mean SD Mean SD p 
NoR 
NoL 
PoR 
PoL 
NaR 
NaL 
PaR 
PaL 
NbR 
NbL 
PbR 
PbL 
10.67 
11.18 
18.05 
19.14 
29.22 
29.98 
40.16 
43.01 
53.44 
55.66 
68.37 
66.54 
3.52 
3.26 
1.55 
3.87 
2.63 
3.55 
3.32 
6.35 
6.73 
10.09 
7.84 
11.07 
8.48 
8.04 
15.71 
15.36 
26.26 
26.65 
37.70 
39.77 
48.01 
48.97 
59.19 
59.35 
2.64 
2.25 
2.39 
2.38 
2.21 
2.79 
2.64 
3.31 
5.37 
3.58 
7.94 
5.76 
NS 
S 
S 
S 
S 
S 
S 
NS 
S 
S 
S 
S 
Table 5. Latencies of MLAEPs (Millisecond). 
 
 Patients  (n=15) Control (n=15)  
 Mean SD Mean SD p 
NoR 
NoL 
PoR 
PoL 
NaR 
NaL 
PaR 
PaL 
NbR 
NbL 
PbR 
PbL 
0.17 
0.22 
0.22 
0.22 
0.39 
0.39 
0.26 
0.26 
0.28 
0.25 
0.27 
0.19 
0.15 
0.15 
0.13 
0.15 
0.35 
0.29 
0.27 
0.25 
0.30 
0.22 
0.29 
0.10 
0.4 
0.47 
0.49 
0.56 
0.86 
0.76 
0.65 
0.58 
0.55 
0.50 
0.48 
0.50 
0.2 
0.27 
0.25 
0.32 
0.50 
0.34 
0.51 
0.33 
0.38 
0.33 
0.38 
0.31 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
NS 
S 
Table 6. Amplitudes of MLAEP Potentials (Microvolt). 
2.4 Discussion 
In this study we found that the many parameters of MLAEPs except NoR and PaL for 
latency and PbR for amplidute, were significantly abnormal in the patient group. Also, the 
neuropsychological test performances of the patient group were poor when compared with 
normals. 
According to our data, there were not any correlations between PANSS scores, the scores of 
neuropsychological test, the duration of disease, and the latencies and amplitudes of 
MLAEPs. 
Although the neural sources of MLAEPs are still controversial, the studies suggest that Pa, 
Pb and Nb components of MLAEPs have a cortical generator (primary auditory cortex and 
adjacent areas) while No, Po, and Na have a brainstem-subcortical generator (medial 
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geniculate body, polysensory thalamic nuclei) (Deiber et al., 1988; Diaz et al., 1990) It is well-
known that human Pb (P1) potential is blocked by scopalamine, muscarinic cholinergic 
antagonists, and due to lesions including cholinergic pedunculopontine nucleus (Diaz et al., 
1990) 
In patients with schizophrenia, the abnormalities in auditory evoked potentials have been 
reported by other studies. Erwin et al. reported that the recovery cycle of the P1 component 
of auditory midlatency evoked potential is abnormal (Erwin et al.,1991). Boutros and 
coworkers suggested that there were morphological abnormalities of the MLAEPs in 
schizophrenia patients (Boutros et al.,2004). Clementz et al.showed that P50 suppression 
was deficient in these patients, indicating sensory gating abnormality (Clementz et al., 1997). 
All these findings were interpreted by authors as a deficiency of generators of MLAEPs, 
underlying neural structures and neurotransmitter systems in patients with schizophrenia. 
We investigated the latency and amplitude features of MLAEPs recorded on dominant and 
non-dominant hemisphere in patients with schizophrenia but not the recovery cycle and 
sensory gating features. All patients and control subjects were strongly right-handed 
according to Edinburgh Inventory (Oldfield et al., 1971). 
Our results revealed statistically significant differences both in latency and amplitudes of 
MLAEP components in the patient group when compared with the normal group.   
Lateralization seems to be important in schizophrenic patients since some symptoms of the 
disease emerge when specific parts of the brain are involved. It was hypothesized that 
hypermetabolism of the left temporal lobe seemed to occur only if the patient was actively 
hallucinating for example (Mesulam et al., 1990). 
In our study the pathological responses elicited from both sides of the brains of patients did 
not differ significantly from each other as both right and left sides generated MLAEPs which 
were statistically significantly different from controls. We believe this is an important 
finding since all our patients and controls were strongly right-handed. Thoma et al. 
concluded in one of their studies that converging evidence from EEG, MEG and 
neuropsychological measures pointed to left hemisphere dysfunction related to the well 
established sensory gating in schizophrenia (Thoma et al., 2003). 
It has been assumed that latency in evoked potential studies reflect the efficiency and speed 
of information processing. Thus, the prolonged latency may reflect that the information 
processing speed slowed. 
Amplitude abnormalites, on the other hand, refer to axonal loss in related areas and show 
the overall efficiency of neural structures mediating a response.  
Amplitude abnormalities in evoked potentials of patients with schizophrenia have been 
reported with much more consistency than latency abnormalities. Munkundan and 
coworkers observed amplitude and recovery abnormalities but normal latencies of MLAEPs 
in schizophrenia patients (Munkundan et al., 1986). Williams and coworkers similarly found 
no latency abnormalities in a group of medicated schizophrenia patients (Williams et al, 
2000). However, Boutros and coworkers demonstrated that schizophrenia patients had 
significantly longer latencies for the P50 and N100 components (Boutros et al., 2004). Our 
findings agree with results of the researchs in literature. 
The many previous studies investigated the neuropsychological profile of the patients  
with schizophrenia. Almost all of these studies demonstrated the neuropsychological 
impairments in the multiple cognitive areas etc. memory, attention, language, executive 
functions (Bozikas et al., 2006; Brazo et al., 2005; Mohamed at al., 1999). However, it is still  
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unknown whether there is a relationship between the neuropsychological impairments and 
neuroanatomical changes. Also, it is unclear whether the negative and positive symptoms 
are associated with a spesific brain region and/or neuropsychological deficits. Andreasen et 
al. and Weinberg et al. have reported that the negative symptoms reflected primarily frontal 
lobe dysfunction (Andreasen, 1986; Weinberger, 1987). Berman et al. observed that negative 
symptoms associated with poor performances on cognitive tests reflected poor frontal lobe 
functions while positive symptoms were associated with poor attention representing 
widespread neural network (Berman et al., 1997). Liu et al. demonstrated that the negative 
schizophrenic patients had executive function deficits and lower rCBF perfusion in left 
prefrontal lobes (Liu et al, 2002). On the other hand, Morrison-Stewart et al. found no 
correlation between frontal lobe assessing neuropsychological tests and negative symptoms 
(Morrison et al., 2002). Addington et al. reported that there was no relationship between 
attention and negative and positive symptoms (Addington et al., 1997). 
The results of our study showed that the cognitive functions assessing the comprehensive 
neuropsychological test battery were statistically significantly worse in the patient group 
when compared with the control group.  
Schizophrenia is a heterogeneous mental disease which is characterized with thought 
disorder, hallucination, delusion and cognitive deficits.45 Postmortem studies showed low 
neuron density, cortical volume reduction, pyramidal cell disarray, neurotransmitter 
disturbances such as glutamate, GABA, dopamine, and acetylcholine (Harrison et al.,1998; 
Sarter et al.,1998; Simpson at al, 1998). The longitudinal studies support that schizophrenia 
is largely a static disorder while others suggest a deteriorating course (Harrison et al.,1998; 
Gur et al., 1998; Vita et al., 1997). 
The spectrum of disease duration of our patients was fairly widespread (min: 50 months 
max: 440 months). In our study there were no correlations between the disease duration, 
severity of the disease (by PANSS), EP measures, and neuropsychological profiles. This may 
perhaps support that schizophrenia is a static disorder rather than progressive.  
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